C&L Research Overview
- Year Founded
-
2023
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Financing Rounds
-
1
C&L Research General Information
Description
Developer of innovative drugs for the treatment of infectious diseases and other serious diseases.
Contact Information
Formerly Known As
Kronen 3067 GmbH
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
- Hermann-Körner Street 52-54
- 21465 Reinbek
- Germany
Primary Industry
Drug Discovery
Acquirer
Dermapharm Holding
Corporate Office
- Hermann-Körner Street 52-54
- 21465 Reinbek
- Germany
C&L Research Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
C&L Research FAQs
-
When was C&L Research founded?
C&L Research was founded in 2023.
-
Where is C&L Research headquartered?
C&L Research is headquartered in Reinbek, Germany.
-
What industry is C&L Research in?
C&L Research’s primary industry is Drug Discovery.
-
Is C&L Research a private or public company?
C&L Research is a Private company.
-
What is the current valuation of C&L Research?
The current valuation of C&L Research is .
-
What is C&L Research’s current revenue?
The current revenue for C&L Research is .
-
When was C&L Research acquired?
C&L Research was acquired on 19-Feb-2024.
-
Who acquired C&L Research?
C&L Research was acquired by Dermapharm Holding and Allergopharma.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
